Brian N. Cunningham, M.D. has served as CBO and SVP Finance since Madrigal was founded in September 2011. A Venture Partner with Bay City Capital, Brian has been extensively involved in BCC’s activities since he joined The Pritzker Organization in 2004. During his tenure at The Pritzker Organization, Dr. Cunningham served in various operational roles with a number of Bay City Capital portfolio companies, most notably Reliant Pharmaceuticals and PTC Therapeutics. Dr. Cunningham has been instrumental in the execution of numerous collaborations and licensing deals, provided oversight of portfolio company financial functions including budgetary responsibilities and advised on clinical development strategies.
Prior to joining The Pritzker Organization, Dr. Cunningham was a Consultant with L.E.K. Consulting, focusing in the biopharmaceutical and medical device sectors.
Prior to joining L.E.K., Dr. Cunningham was a Research Fellow at the Cleveland Clinic Foundation in the Department of Plastic and Reconstructive Surgery. After matriculating in a combined BS/M.D. program, he received his medical degree with honors in 2001 from Northeastern Ohio University College of Medicine.
Dr. Cunningham is treasurer and a founding trustee of Advancing Innovation in Dermatology.
Dermatology is recognized as a burgeoning area with exciting innovation for patients, doctors, and investors.
Pascale Communications was on the scene at the annual American Academy of Dermatology (AAD).
DENVER — R. Rox Anderson, MD, professor of dermatology at Harvard Medical School and director of the Wellman Center for …